Provided by Tiger Trade Technology Pte. Ltd.

Arcus Biosciences Inc.

18.92
-1.0400-5.21%
Post-market: 18.920.00000.00%16:10 EST
Volume:1.44M
Turnover:27.76M
Market Cap:2.30B
PE:-5.59
High:20.53
Open:20.17
Low:18.81
Close:19.96
52wk High:26.40
52wk Low:6.50
Shares:121.67M
Float Shares:75.23M
Volume Ratio:1.62
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3871
EPS(LYR):-3.1410
ROE:-68.13%
ROA:-21.06%
PB:5.28
PE(LYR):-6.02

Loading ...

Wells Fargo Downgrades Arcus Biosciences to Equal Weight From Overweight, Adjusts PT to $23 From $30

MT Newswires Live
·
Feb 12

Arcus Biosciences Inc : Wells Fargo Cuts to Equal Weight From Overweight

THOMSON REUTERS
·
Feb 12

Wells Fargo downgrades Arcus Biosciences (RCUS) to a Hold

TIPRANKS
·
Feb 12

Arcus Biosciences Inc. to Host Conference Call on Financial Results and Pipeline Update

Reuters
·
Feb 12

Arcus Biosciences Grants Stock Options and Restricted Stock Units to New Employees

Reuters
·
Jan 27

Arcus’ 2026 Oncology Readouts And Phase 3 Progress Might Change The Case For Investing In RCUS

Simply Wall St.
·
Jan 17

Arcus Biosciences upgraded to Buy from Neutral at Goldman Sachs

TIPRANKS
·
Jan 13

Arcus Biosciences Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
Jan 08

BRIEF-Arcus Outlines Plans For Casdatifan And Its Inflammation Programs

Reuters
·
Jan 08

Arcus Biosciences Inc - Plans Three Data Readouts for Casdatifan in 2026

THOMSON REUTERS
·
Jan 08

Arcus Biosciences Inc - Expects to Fund Operations Until Second Half of 2028

THOMSON REUTERS
·
Jan 08

Arcus Biosciences President Juan C. Jaen Reports Sale of Common Shares

Reuters
·
Jan 08

Arcus Biosciences CFO Robert C. Goeltz II Reports Disposal of Common Shares

Reuters
·
Jan 03

Have Insiders Sold Arcus Biosciences Shares Recently?

Simply Wall St.
·
Dec 20, 2025

Arcus Biosciences President Juan C. Jaen Reports Sale of Common Shares

Reuters
·
Dec 19, 2025

Arcus Biosciences Inc - First Amendment Extends Maturity Date to Sept 1, 2030, With No Further Extension Right- SEC Filing

THOMSON REUTERS
·
Dec 19, 2025

Arcus Biosciences Inc - Amendment Changes Terms for $150 Mln Loan Commitments - SEC Filing

THOMSON REUTERS
·
Dec 19, 2025

Arcus Biosciences Amends Loan Agreement to Access Up to $150 Million in New Financing

Reuters
·
Dec 19, 2025

Arcus Biosciences CEO to Present at J.P. Morgan Healthcare Conference

Reuters
·
Dec 19, 2025

Arcus Revamps Cancer Pipeline Following Trial Miss, Prioritizes Kidney Drug

Benzinga_recent_news
·
Dec 13, 2025